• BD

      BD Medical – Pharmaceutical Systems provides customized, clinically-proven drug delivery systems and self-injection technologies to help pharmaceutical customers’ injectable drugs reach their full potential.  BD is committed to building partnerships to develop product solutions that meet evolving customer needs by leveraging innovative technologies, global manufacturing and advanced technical and scientific expertise.
      http://www.bd.com

    • BioChemics

      BioChemics Inc., is a specialty pharmaceutical company that has developed a novel, transdermal, gel based drug delivery system for the first time that may allow almost any drug to be efficiently delivered through the skin. The transdermal technology, called Vaso-active Lipid Encapsulated (VALE®), may allow a substantial portion of the pharmacopeia to be re-engineered, turning oral drugs into transdermals that are safer (no gastro-intestinal problems), cheaper and potentially faster acting (applied directly to the treated area) than oral equivalents.
      http://www.biochemics.com

    • Flextronics

      Flextronics Medical helps pharmaceutical and medical device customers become more competitive by bringing innovative products to market faster and at lower costs through world-class integrated design, manufacturing, and logistics services with a commitment to quality and service in everything we do.

       

      Flextroincs Medical’s end-to-end solutions are available in North America, Europe and Asia.

      http://www.flextronics.com

    • IntecPharma

      Intec Pharma Ltd. (TASE: INTP), founded in 2003, has developed a patented, Gastro-retentive system (Accordion Pill®) to enhance drugs that are:
      - Absorbed or act mainly in the upper GI region
      - Poorly soluble.
      Gastric retention is achieved under a regular calorie diet.


      Intec's pipeline includes inter-alia:
      1. AP-Carbidopa/Levodopa for Parkinson's disease , phase II (Israel)
      2. AP-Zaleplon for Insomnia, phase II (US)
      3. Programs under collaborations with global pharmaceutical companies.

      http://www.intecpharma.com

    • LTS Lohmann Therapy Systems

      LTS Lohmann Therapie-Systeme AG is a world class developer and manufacturer of transdermal systems, oral film drug delivery systems and adhesive laminates. We use leading edge technology to manufacture developed products on a large and cost effective commercial scale. LTS develops products from inception through commercialisation in our facilities in Germany and U.S.A. under GMP conditions, both approved by the FDA and European Authorities.

       

      LTS’ partners are many of the world’s successful pharmaceutical, consumer healthcare, medical device and diagnostic companies.

       

      Our resources include: research & development, clinical pharmacology, technology transfer, analytical, regulatory affairs, quality assurance, operations and product support.

      http://www.ltslohmann.com/

    • MedPro Safety Products

      MedPro Safety Products is “turning prefilled upside down”.  The company’s latest drug delivery device continues to protect healthcare workers through true, passive needlestick protection while making the transition to a “prefilled” device easier for pharmaceutical companies by keeping the primary container a standard drug cartridge.  Every needle, every time.
      http://www.medprosafety.com

    • Novaliq GmbH

      Novaliq GmbH, Heidelberg, Germany, offers a new drug delivery technology for poorly soluble drugs, semi-fluororinated alkanes (SFA). This patented, non-aqueous and preservative-free approach offers a range of unique features and represents therefore an interesting alternative to aqueous based ophthalmic formulations. A prominent example is cyclosporine A.
      http://www.novaliq.de

    • Pantec Biosolutions

      Injection free intraepidermal drug delivery.
      Pantec Biosolutions AG develops and commercialises a laser-powered skin microporation method (P.L.E.A.S.E.® - Painless laser epidermal system) prior to drug patch application, which extends the range of drugs that can be delivered transdermally to large molecular weight drugs. This novel application allows delivering the drugs directly into the epidermis in a dose controlled way, avoiding painful injections.

      The company's first focus is to replace around hundred injections applied during hormone therapy in In Vitro Fertilisation (IVF).

      Drug patch development for IVF hormones is underway, and the company will commercialise the product solution "P.L.E.A.S.E.® - device plus drug patches" with a Pharma partner company. Further interesting therapeutic areas are in preclinical development.

      http://www.pantec-biosolutions.com